The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Karray, S.
Right arrow Articles by Zouali, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karray, S.
Right arrow Articles by Zouali, M.
The Journal of Immunology, 1998, 161: 6681-6688.
Copyright © 1998 by The American Association of Immunologists

Structural Basis of the gp120 Superantigen-Binding Site on Human Immunoglobulins1

Saoussen Karray2,*, Laure Juompan3,*, Rachid C. Maroun{dagger}, David Isenberg{ddagger}, Gregg J. Silverman§ and Moncef Zouali4,*

* Département d’Immunologie and {dagger} Unité des Venins, Institut Pasteur, Paris, France; {ddagger} Centre for Rheumatology, Bloomsbury Rheumatology Unit, Department of Medicine, University College London, London, United Kingdom; and § Department of Medicine, School of Medicine, University of California, San Diego, La Jolla, CA 92093

B cell superantigens (SAg) interact with normal human nonimmune Igs (Igs), independently of the light chain isotype, and activate a large proportion of the B cell repertoire. Recently, the major envelope protein of HIV-1, gp120, was found to exhibit SAg-like properties for B cells with potential pathologic consequences for the infected host. This unconventional mode of interaction contrasts with its binding to immunization-induced Abs, which requires the tertiary structure of the heavy and light chain variable regions. In this report, we have examined the structural basis of the interaction between human Igs and gp120. We found that gp120 binding is restricted to Igs from the VH3 gene family and that the two VH genes 3-23 and 3-30, known to be overutilized during all stages of B cell development, frequently impart gp120 binding. We also provide evidence that the viral gp120 SAg can interact with only a subset of the human VH3+ Igs that can convey binding to the prototypic bacterial B cell SAg protein A from Staphylococcus aureus. Finally, we have identified amino acid positions present primarily in the first and third framework regions of the Ig heavy chain variable region, outside the conventional hypervariable loops, which correlate with gp120 binding. In a three-dimensional sequence-homology model, these residues partially overlap with the predicted SAg protein A binding site for VH3+ Igs.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. Nishiyama, S. Planque, Y. Mitsuda, G. Nitti, H. Taguchi, L. Jin, J. Symersky, S. Boivin, M. Sienczyk, M. Salas, et al.
Toward Effective HIV Vaccination: INDUCTION OF BINARY EPITOPE REACTIVE ANTIBODIES WITH BROAD HIV NEUTRALIZING ACTIVITY
J. Biol. Chem., October 30, 2009; 284(44): 30627 - 30642.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. D. Pashov, J. Plaxco, S. V. Kaveri, B. Monzavi-Karbassi, D. Harn, and T. Kieber-Emmons
Multiple Antigenic Mimotopes of HIV Carbohydrate Antigens: Relating Structure and Antigenicity
J. Biol. Chem., October 6, 2006; 281(40): 29675 - 29683.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Paul, S. Karle, S. Planque, H. Taguchi, M. Salas, Y. Nishiyama, B. Handy, R. Hunter, A. Edmundson, and C. Hanson
Naturally Occurring Proteolytic Antibodies: SELECTIVE IMMUNOGLOBULIN M-CATALYZED HYDROLYSIS OF HIV gp120
J. Biol. Chem., September 17, 2004; 279(38): 39611 - 39619.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Viau, N. S. Longo, P. E. Lipsky, L. Bjorck, and M. Zouali
Specific In Vivo Deletion of B-Cell Subpopulations Expressing Human Immunoglobulins by the B-Cell Superantigen Protein L
Infect. Immun., June 1, 2004; 72(6): 3515 - 3523.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. W. Scamurra, D. B. Nelson, X. M. Lin, D. J. Miller, G. J. Silverman, T. Kappel, J. R. Thurn, E. Lorenz, A. Kulkarni-Narla, and E. N. Janoff
Mucosal Plasma Cell Repertoire During HIV-1 Infection
J. Immunol., October 1, 2002; 169(7): 4008 - 4016.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. W. Scamurra, D. J. Miller, L. Dahl, M. Abrahamsen, V. Kapur, S. M. Wahl, E. C. B. Milner, and E. N. Janoff
Impact of HIV-1 Infection on VH3 Gene Repertoire of Naive Human B Cells
J. Immunol., May 15, 2000; 164(10): 5482 - 5491.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. N. Neshat, L. Goodglick, K. Lim, and J. Braun
Mapping the B cell superantigen binding site for HIV-1 gp120 on a VH3 Ig
Int. Immunol., March 1, 2000; 12(3): 305 - 312.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Patella, G. Florio, A. Petraroli, and G. Marone
HIV-1 gp120 Induces IL-4 and IL-13 Release from Human Fc{epsilon}RI+ Cells Through Interaction with the VH3 Region of IgE
J. Immunol., January 15, 2000; 164(2): 589 - 595.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Montesinos-Rongen, R. Kuppers, D. Schluter, T. Spieker, D. Van Roost, C. Schaller, G. Reifenberger, O. D. Wiestler, and M. Deckert-Schluter
Primary Central Nervous System Lymphomas Are Derived from Germinal-Center B Cells and Show a Preferential Usage of the V4-34 Gene Segment
Am. J. Pathol., December 1, 1999; 155(6): 2077 - 2086.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
Z. Zhong, T. Burns, Q. Chang, M. Carroll, and L. Pirofski
Molecular and Functional Characteristics of a Protective Human Monoclonal Antibody to Serotype 8 Streptococcus pneumoniae Capsular Polysaccharide
Infect. Immun., August 1, 1999; 67(8): 4119 - 4127.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.